CALCIUM CHLORIDE- calcium chloride injection injection, solution

Country: Amerika Syarikat

Bahasa: Inggeris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

CALCIUM CHLORIDE (UNII: M4I0D6VV5M) (CALCIUM CATION - UNII:2M83C4R6ZB, CHLORIDE ION - UNII:Q32ZN48698)

Boleh didapati daripada:

Medical Purchasing Solutions, LLC

Laluan pentadbiran:

INTRAVENOUS

Jenis preskripsi:

PRESCRIPTION DRUG

Tanda-tanda terapeutik:

10% Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. Safety and effectiveness are based on similar clinical conditions in children and adults. An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. None known.

Ringkasan produk:

10% Calcium Chloride Injection, USP is supplied in single-dose containers as follows: Container NDC 64253-900-36 10 mL Single-dose prefilled syringes, individually pouched, in a carton of 60s. Plastic 1000 mg/10 mL NDC 64253-900-30 10mL fill in 12mL Syringe Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Do not freeze.

Status kebenaran:

Abbreviated New Drug Application

Ciri produk

CALCIUM CHLORIDE- CALCIUM CHLORIDE INJECTION INJECTION, SOLUTION
MEDICAL PURCHASING SOLUTIONS, LLC
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE 10%
CALCIUM CHLORIDE
INJECTION, USP SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING
INFORMATION FOR 10% CALCIUM
CHLORIDE INJECTION, USP.
10% CALCIUM CHLORIDE INJECTION, USP FOR INTRAVENOUS INJECTION
INITIAL U.S. APPROVAL: 2019
INDICATIONS AND USAGE
(3)
10% Calcium Chloride Injection, USP is indicated for the treatment of
hypocalcemia in those conditions
requiring a prompt increase in plasma calcium levels. (3)
CONTRAINDICATIONS
Calcium chloride is contraindicated for cardiac resuscitation in the
presence of ventricular fibrillation or in
patients with the risk of existing digitalis toxicity. (4)
Calcium chloride is not recommended in the treatment of asystole and
electromechanical dissociation. (4)
ADVERSE REACTIONS
Rapid injection may cause the patient to complain of tingling
sensations, a calcium taste, a sense of
oppression or "heat wave".
Injections of calcium chloride are accompanied by peripheral
vasodilatation as well as a local "burning"
sensation and there may be a moderate fall in blood pressure.
Should perivascular infiltration occur, I.V. administration at that
site should be discontinued at once. Local
infiltration of the affected area with 1% procaine hydrochloride, to
which hyaluronidase may be added, will
often reduce venospasm and dilute the calcium remaining in the tissues
locally. Local application of heat
may also be helpful.
To report SUSPECTED ADVERSE REACTIONS, contact Medefil, Inc., at
1-630-682-4600 or
www.medefilinc.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
DOSAGE AND ADMINISTRATION
10% Calcium Chloride Injection, USP is administered only by slow
intravenous injection (not to exceed 1
mL/min), preferably in a central or deep vein. (14)
The usual precautions for intravenous therapy should be observed. If
time permits, the solution should be
warmed to body temperature. T